Explores the complexity and fundamental capabilities of cancer, focusing on hallmarks like sustained proliferative signaling and evading growth suppressors.
Explores tumor immune evasion, drug delivery challenges, and nanoparticle strategies in cancer treatment, including the impact of checkpoint inhibitors and hydrogels.
Introduces the emerging field of immunoengineering, covering interactions between engineering and immunology, genetically engineered immune cells for cancer therapy, and key technologies in immunological analysis.
